Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients
Podoltsev N, Bustillo I, Yao X, Liu H, Cooper D. Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients. Blood 2011, 118: 4941. DOI: 10.1182/blood.v118.21.4941.4941.Peer-Reviewed Original ResearchReduction of immunosuppressionDiffuse large B-cell lymphomaYale Cancer CenterMonomorphic PTLDPolymorphic PTLDPTLD patientsGraft lossGraft rejectionComplete responseB cellsMedian progression-free survivalSolid organ transplantation recipientsEpstein-Barr virus infectionLarge B-cell lymphomaEBV-negative tumorsGraft loss rateStandard immunosuppressive agentsMedian overall survivalAdvanced stage diseaseConsequence of immunosuppressionEBV-positive lymphomasOrgan transplantation recipientsProgression-free survivalRetrospective cohort trialTime of diagnosis